KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 3 filers reported holding KARUNA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 3.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,300 | -42.8% | 55 | -26.7% | 0.01% | -33.3% |
| Q2 2023 | $16,264 | +19.4% | 75 | 0.0% | 0.01% | +9.1% |
| Q1 2023 | $13,623 | -7.6% | 75 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $14,738 | -13.3% | 75 | 0.0% | 0.01% | -26.7% |
| Q3 2022 | $17,000 | +88.9% | 75 | 0.0% | 0.02% | +114.3% |
| Q2 2022 | $9,000 | -10.0% | 75 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $10,000 | 0.0% | 75 | 0.0% | 0.01% | +16.7% |
| Q4 2021 | $10,000 | -60.0% | 75 | -63.4% | 0.01% | -66.7% |
| Q3 2021 | $25,000 | +19.0% | 205 | +9.6% | 0.02% | +20.0% |
| Q2 2021 | $21,000 | +5.0% | 187 | +10.0% | 0.02% | -6.2% |
| Q1 2021 | $20,000 | – | 170 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 908,708 | $109,254,000 | 35.05% |
| Sofinnova Investments, Inc. | 1,952,441 | $234,742,000 | 14.11% |
| Logos Global Management LP | 200,000 | $24,046,000 | 2.35% |
| First Light Asset Management, LLC | 258,500 | $31,079,000 | 2.06% |
| Eventide Asset Management | 971,077 | $116,753,000 | 1.73% |
| DAFNA Capital Management LLC | 48,000 | $5,771,000 | 1.37% |
| CATALYST PRIVATE WEALTH, LLC | 13,006 | $1,564,000 | 1.10% |
| Rock Springs Capital Management LP | 368,764 | $44,336,000 | 0.97% |
| Pinz Capital Management, LP | 28,805 | $3,463,000 | 0.92% |
| MILLER VALUE PARTNERS, LLC | 291,239 | $35,016,000 | 0.91% |